Retatrutide research peptide supplied for laboratory studies of GIP, GLP-1, and glucagon receptor activity and related molecular interactions.
| Feature | Details |
| Product Name | Retatrutide 20mg |
| Brand | Hemi Pharma |
| Active Compound | Retatrutide (LY3437943) |
| Quantity | 20 mg |
| Vial | 10 ml |
| Category | Research Use Only (RUO) |
| Peptide Type | Synthetic peptide |
| Receptor Targets | GIP, GLP-1, and glucagon receptors |
| Research Areas | Receptor biology, hormone signaling, metabolic research, and molecular interactions |
| Limitations | Only for laboratory investigation of GIP, GLP-1, and glucagon receptor activity, related signaling, and metabolic biology |
£120.00
Smart Packaging
Secure Payment
14-Day Returns
Retatrutide 20mg by Hemi Pharma contains retatrutide that is an investigational single molecule, identifies as LY3437943. It acts as a triple-receptor agonist at the GIP, GLP-1, and glucagon receptors. This combination gives the molecule a distinct profile for laboratory research into multi-receptor signaling.
Research on retatrutide examines how simultaneous activity across these receptor systems can be studied in relation to hormone signaling and metabolic biology. The molecule has also been characterized through biochemical and pharmacological studies, including research into its structure and molecular properties.
£41.00
£120.00
£34.00
